Yazen

What Yazen does

Yazen is a Swedish digital healthcare company founded in 2021 and headquartered in Lund/Malmö that operates one of Europe's largest digital obesity clinics. The company delivers medically supervised weight loss treatment through a three-phase subscription program (Connect, Change, Clarity) that combines GLP-1/GIP medications with multidisciplinary lifestyle support from physicians, dietitians, psychologists, personal trainers, and dedicated YazenCoaches. Its core technology is the Yazen App, a telemedicine platform enabling patients to track progress, communicate with their care team, access the Yazen Commit learning program, and participate in the Yazen Community.

Yazen generates revenue through monthly subscriptions starting at SEK 995 (~€87), with medication costs billed separately, producing a recurring revenue stream with high customer lifetime value. Patients are acquired primarily through DTC digital channels — SEO, the BMI calculator tool, content marketing, app store listings, and paid social — with marketing investment exceeding €17.8 million in 2025. The company employs 251-500 staff and operates across seven European markets (Sweden, Norway, Denmark, Netherlands, UK, Germany, Spain), serving over 37,000 active patients and reporting 50,000+ success stories with an average 20% body weight loss in the first year.

The business is venture-backed, having raised approximately €22.6 million in equity (€3.1M seed in 2023, €19.5M growth round in 2024) plus a €6.5M debt facility from HSBC Innovation Banking in 2026. The Medstart acquisition in December 2024 expanded Yazen into Denmark and strengthened its Nordic footprint. Leadership includes CEO Fredrik Meurling and Chairman Mikael Hed. Revenue reached approximately €29.4M in 2025 with ARR of SEK 372M, though EBITDA remained negative at -€5.7M due to growth investments.

Name

Yazen

Legal name

Yazen

Website

https://yazen.se

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

251–500 employees

Short description

Yazen is a Swedish-founded digital obesity clinic providing medically supervised GLP-1 weight loss treatment with multidisciplinary coaching across seven European markets, serving over 37,000 active patients on a monthly subscription model.

Ownership category

akta.pro rank

Product category

Digital Obesity Care

NAICS

Other Ambulatory Health Care Services (6219)

SIC

Services-Health Services (8000)

akta.pro primary industry

Obesity Medicine & Weight Management (HLAKADAL)

Keywords

• Digital obesity treatment
• Medical weight loss
• GLP-1 telemedicine
• Telehealth weight management
• Obesity care platform

Headquarters

HQ city

Lund

HQ country

Sweden

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Marketing or Sales, Personnel, Operations, Technology or R&D, Others

Revenue model

1. Subscription-based treatment services: Yazen generates revenue through monthly subscription fees for its digital obesity treatment program. Patients pay a monthly fee (starting from 995 kr) for access to the medical treatment team, app-based tools, personalized treatment plans, and ongoing support. The subscription model provides recurring revenue with high customer lifetime value. Note: Medication costs are not included in the subscription price.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Yazen is a digital obesity clinic providing medically supervised weight loss treatment through a subscription-based program that combines GLP-1/GIP analog medications with multidisciplinary lifestyle support (doctors, dietitians, psychologists, personal trainers, and dedicated YazenCoaches). The service is delivered via the Yazen App, structured in three phases (Connect onboarding, Change active treatment, Clarity maintenance), with patients paying a monthly subscription starting at SEK 995 plus separate medication costs.

Product overview

Yazen is a digital obesity clinic offering a unified platform-and-module product architecture. The core product is the Yazen App, which serves as the central hub for patients to access their medical obesity treatment program. The treatment program itself integrates GLP-1/GIP medication with lifestyle coaching and is delivered through three phases (Connect, Change, Clarity). The app supports several add-on modules: YazenCoach (personalized coaching), Yazen Commit (behavioral learning program), and Yazen Community (peer support forums). Together, these components provide end-to-end digitally delivered, medically supervised weight loss care.

Differentiator

Problem solved

Functional benefit

Products and services

• Yazen App Mobile and web application that serves as the central hub for patients to access their Yazen treatment team, track weight-loss progress, chat with coaches and medical staff, use lifestyle tools, and participate in the Yazen Commit learning program. Available on iOS App Store and Google Play for individual patients across Yazen's seven European markets.
• Medical Obesity Treatment Program A medically supervised weight-loss subscription program combining approved GLP-1/GIP analog medications with lifestyle interventions, supported by a multidisciplinary team of physicians, dietitians, psychologists, personal trainers and dedicated YazenCoaches. Delivered in three phases — Connect (onboarding with blood test and consultation), Change (active treatment from SEK 995/month), and Clarity (maintenance) — for adults with BMI ≥27 across Sweden, Norway, Denmark, Netherlands, UK, Germany, and Spain.

Quantifiable outcome

• Patients lose an average of 20% of their body weight during the first year of treatment.
• +3 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• MedstartcoreStrategic or Co-development Partner · 21 December 2024Yazen acquired Danish healthcare company Medstart to expand into Denmark and strengthen its presence in Norway. The acquisition follows Yazen's €19.5 million investment and aims to integrate Medstart into its European expansion plan by 2025. This acquisition supports Yazen's focus on digital solutions and innovative medications to improve obesity care across Europe.

Scale indicators11 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Kry (Livi): Kry is a leading European telehealth provider headquartered in Sweden, offering video consultations with doctors across multiple specialties. Comparable to Yazen as a Swedish-founded digital health platform serving multiple European countries.
• WeightWatchers (WW International): WeightWatchers is a legacy global weight management brand that has pivoted to include GLP-1 medication access via telehealth. Comparable to Yazen in target customer and weight loss offering, but operates at much larger scale with a broader portfolio.

Direct peers

• Ro: Ro is a US telehealth company operating across multiple verticals including weight loss through its Body Program. Overlaps with Yazen in its D2C telemedicine + medication model targeting chronic conditions.
• Hims & Hers Health: Hims & Hers is a large US telehealth platform that has expanded into weight loss via GLP-1 prescriptions. Comparable to Yazen as a digital-first subscription provider combining telemedicine with prescription medication for obesity.
• Noom: Noom is a D2C digital weight loss platform combining coaching, app-based tools, and now GLP-1 medication support. Directly comparable to Yazen in its subscription-based digital weight management model with multidisciplinary coaching.
• Found: Found is a US-based digital weight loss company offering GLP-1 medication combined with lifestyle coaching via an app-based subscription. Closely mirrors Yazen's combined medication + coaching D2C model.
• Oviva: Oviva is a European digital health provider offering app-based lifestyle and weight management programs, often reimbursed by insurers. Comparable to Yazen as a digital obesity treatment provider active across multiple European markets.
• Calibrate: Calibrate is a digital metabolic health company focused on sustainable weight loss using GLP-1 medications alongside coaching. Comparable to Yazen in its medically supervised, app-driven subscription obesity treatment model.

Regional players

• Zava: Zava is a European online doctor and pharmacy service operating across the UK, Germany, France, and Ireland. Comparable to Yazen as a D2C digital health platform offering prescription treatments across multiple European markets.
• Doktor.se: Doktor.se is a Swedish digital primary care provider offering app-based doctor consultations. Comparable to Yazen in its Swedish telemedicine roots and digital healthcare delivery model, though focused on broader primary care.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/yazensverige.se
• LinkedInlinkedin.com/company/yazen-health

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds5 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Yazen